A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Halifax, Farmington CT, New Haven CT, Mineola NY,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07258511
Phase3, Recruiting
Confirming the Effects of Acupuncture Treatments to Relieve Symptoms of Gulf War Illness
for
Persian Gulf Syndrome, Gulf War Syndrome,
Location: Tampa FL, Dallas TX, Los Angeles CA
Sponsor: University of Utah
Sex: All
Age: 18+
Code: NCT06716411
Recruiting
A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma
for
Multiple Myeloma, Secondary Immunodeficiency
Location: Albany NY, Montreal, Baltimore MD, Detroit MI,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT06980480
Phase3, Recruiting
A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients
for
Multiple Myeloma
Location: Irvine CA, Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT07225738
Recruiting
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
for
Multiple Myeloma (MM)
Location: New York NY, Brooklyn NY, Baltimore MD, Durham NC,
Sponsor: C4 Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07280013
Phase1, Recruiting
Interested in new multiple sclerosis trials?
Get alerts for new trials in your area by subscribing now
Mezigdomide, Carfilzomib, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma in Patients With Extramedullary Disease
for
Extramedullary Disease in Multiple Myeloma,
Location: Buffalo NY
Sponsor: Roswell Park Cancer Institute
Sex: All
Age: 18+
Code: NCT06627751
Phase2, Recruiting
An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers
for
Lymphoma, Multiple Myeloma
Location: St Louis MO
Sponsor: Washington University School of Medicine
Sex: All
Age: 18 - 70+
Code: NCT07226934
Recruiting
Cilta-Talq Fusion Study: A Phase 1b Study of Talquetamab Bridging Therapy Followed by Ciltacabtagene Autoleucel in Patients With Relapsed/Refractory Multiple Myeloma
A Study to Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel
for
Multiple Myeloma
Location: Cleveland OH, San Francisco CA
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18 - 70+
Code: NCT07149857
Phase2, Recruiting
A Dietary Study for People With Multiple Myeloma
for
Multiple Myeloma
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18+
Code: NCT07226609
Recruiting
Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial
for
Multiple Myeloma
Location: Atlanta GA
Sponsor: Emory University
Sex: All
Age: 18+
Code: NCT07101445
Recruiting
Use of Isatuximab, Dexamethasone and Lenalidomide in a Go-Slow Fashion for Ultra-Frail Patients With Multiple Myeloma
for
Multiple Myeloma, Plasma Cell Leukemia
Location: Salt Lake City UT
Sponsor: University of Utah
Sex: All
Age: 18+
Code: NCT06517017
Phase2, Recruiting
A Pilot Clinical Trial Comparing Topical Fluorouracil to Fluorouracil Plus Calcipotriene Field Treatments in Patients With Multiple Actinic Keratoses
for
Multiple Actinic Keratoses
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06851507
Phase3, Recruiting
An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy
for
Multiple System Atrophy
Location: New York NY, Boca Raton FL, Pittsburgh PA, Tampa FL,